Silver Book Fact

Drug-resistant infections increase length & cost of hospital stays

Drug-resistant infections increase the length of hospital stays by more than 23% and the cost by close to 30%.

Mauldin, Patrick D., Cassandra D. Salgado, Ida Solhoj Hansen, Darshana T. Durup, and John A. Bosso. Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria. Antimicrob Agents Chemother. 2009; 54(1): 109-15. http://aac.asm.org/content/54/1/109.full

Reference

Title
Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria
Publication
Antimicrob Agents Chemother
Publication Date
2009
Authors
Mauldin, Patrick D., Cassandra D. Salgado, Ida Solhoj Hansen, Darshana T. Durup, and John A. Bosso
Volume & Issue
Volume 54, Issue 1
Pages
109-15
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • HAIs cost patients additional $43,000 per hospital stay
    Patients with HAIs cost, on average, $43,000 more per hospital stay than those without an infection ($52,096 vs. $9,377).  
  • Antibacterial resistant pathogens responsible for most of 99,000 HAI related deaths
    The majority of the 99,000 patients who die from healthcare-associated infections each year, are due to antibacterial-resistant pathogens.  
  • ~70% of hospital HAIs resistant to ≥ antimicrobial
    Approximately 70% of hospital-acquired HAIs are resistant to at least one antimicrobial drug.  
  • Drug-resistant infections increase length & cost of hospital stays
    Drug-resistant infections increase the length of hospital stays by more than 23% and the cost by close to 30%.  
  • Sepsis accounts for nearly 1/2 of ICU expenditures
    Infection and related sepsis/septicemia account for 40% of all ICU expenditures.